ArticleChemMedChem2016

Norbenzomorphan Framework as a Novel Scaffold for Generating Sigma 2 Receptor/PGRMC1 Subtype-Selective Ligands.

James J Sahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.